vs
ICU MEDICAL INC（ICUI）与Kosmos Energy Ltd.（KOS）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是Kosmos Energy Ltd.的1.8倍（$540.7M vs $294.6M），ICU MEDICAL INC同比增速更快（-14.1% vs -25.9%），过去两年ICU MEDICAL INC的营收复合增速更高（-2.3% vs -16.5%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
科斯莫斯能源是一家美国上游石油企业，总部位于得克萨斯州达拉斯。公司目前在加纳、赤道几内亚近海以及墨西哥湾开展油气生产与开发业务，在毛里塔尼亚、塞内加尔近海拥有开发项目，还在纳米比亚、圣多美和普林西比、苏里南近海持有勘探许可。
ICUI vs KOS — 直观对比
营收规模更大
ICUI
是对方的1.8倍
$294.6M
营收增速更快
ICUI
高出11.7%
-25.9%
两年增速更快
ICUI
近两年复合增速
-16.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $294.6M |
| 净利润 | $-15.7M | — |
| 毛利率 | 37.5% | — |
| 营业利润率 | 1.0% | -125.7% |
| 净利率 | -2.9% | — |
| 营收同比 | -14.1% | -25.9% |
| 净利润同比 | 34.0% | — |
| 每股收益（稀释后） | $-0.63 | $-0.80 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUIKOS
| Q4 25 | $540.7M | $294.6M | ||
| Q3 25 | $537.0M | $311.0M | ||
| Q2 25 | $548.9M | $392.6M | ||
| Q1 25 | $604.7M | $290.1M | ||
| Q4 24 | $629.8M | $397.6M | ||
| Q3 24 | $589.1M | $407.8M | ||
| Q2 24 | $596.5M | $447.8M | ||
| Q1 24 | $566.7M | $422.3M |
净利润ICUIKOS
| Q4 25 | $-15.7M | — | ||
| Q3 25 | $-3.4M | $-124.3M | ||
| Q2 25 | $35.3M | $-87.7M | ||
| Q1 25 | $-15.5M | $-110.6M | ||
| Q4 24 | $-23.8M | — | ||
| Q3 24 | $-33.0M | $45.0M | ||
| Q2 24 | $-21.4M | $59.8M | ||
| Q1 24 | $-39.5M | $91.7M |
毛利率ICUIKOS
| Q4 25 | 37.5% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 37.9% | — | ||
| Q1 25 | 34.7% | — | ||
| Q4 24 | 36.1% | — | ||
| Q3 24 | 34.8% | — | ||
| Q2 24 | 34.8% | — | ||
| Q1 24 | 32.7% | — |
营业利润率ICUIKOS
| Q4 25 | 1.0% | -125.7% | ||
| Q3 25 | 2.6% | -34.2% | ||
| Q2 25 | 1.9% | -16.2% | ||
| Q1 25 | 2.1% | -32.4% | ||
| Q4 24 | 6.0% | -8.5% | ||
| Q3 24 | 1.4% | 26.1% | ||
| Q2 24 | 1.3% | 30.2% | ||
| Q1 24 | -1.9% | 33.6% |
净利率ICUIKOS
| Q4 25 | -2.9% | — | ||
| Q3 25 | -0.6% | -40.0% | ||
| Q2 25 | 6.4% | -22.3% | ||
| Q1 25 | -2.6% | -38.1% | ||
| Q4 24 | -3.8% | — | ||
| Q3 24 | -5.6% | 11.0% | ||
| Q2 24 | -3.6% | 13.3% | ||
| Q1 24 | -7.0% | 21.7% |
每股收益（稀释后）ICUIKOS
| Q4 25 | $-0.63 | $-0.80 | ||
| Q3 25 | $-0.14 | $-0.26 | ||
| Q2 25 | $1.43 | $-0.18 | ||
| Q1 25 | $-0.63 | $-0.23 | ||
| Q4 24 | $-0.97 | $0.00 | ||
| Q3 24 | $-1.35 | $0.09 | ||
| Q2 24 | $-0.88 | $0.12 | ||
| Q1 24 | $-1.63 | $0.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $91.5M |
| 总债务越低越好 | — | $3.1B |
| 股东权益账面价值 | $2.1B | $528.6M |
| 总资产 | $4.1B | $4.7B |
| 负债/权益比越低杠杆越低 | — | 5.78× |
8季度趋势，按日历期对齐
现金及短期投资ICUIKOS
| Q4 25 | — | $91.5M | ||
| Q3 25 | — | $64.0M | ||
| Q2 25 | — | $51.7M | ||
| Q1 25 | — | $49.8M | ||
| Q4 24 | $308.6M | $85.0M | ||
| Q3 24 | $312.5M | $51.6M | ||
| Q2 24 | $302.6M | $173.8M | ||
| Q1 24 | $251.4M | $254.3M |
总债务ICUIKOS
| Q4 25 | — | $3.1B | ||
| Q3 25 | — | $3.0B | ||
| Q2 25 | — | $2.9B | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ICUIKOS
| Q4 25 | $2.1B | $528.6M | ||
| Q3 25 | $2.1B | $898.8M | ||
| Q2 25 | $2.1B | $1.0B | ||
| Q1 25 | $2.0B | $1.1B | ||
| Q4 24 | $2.0B | $1.2B | ||
| Q3 24 | $2.0B | $1.2B | ||
| Q2 24 | $2.0B | $1.1B | ||
| Q1 24 | $2.1B | $1.1B |
总资产ICUIKOS
| Q4 25 | $4.1B | $4.7B | ||
| Q3 25 | $4.1B | $5.1B | ||
| Q2 25 | $4.1B | $5.2B | ||
| Q1 25 | $4.2B | $5.3B | ||
| Q4 24 | $4.2B | $5.3B | ||
| Q3 24 | $4.3B | $5.5B | ||
| Q2 24 | $4.3B | $5.4B | ||
| Q1 24 | $4.3B | $5.4B |
负债/权益比ICUIKOS
| Q4 25 | — | 5.78× | ||
| Q3 25 | — | 3.31× | ||
| Q2 25 | — | 2.80× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.29× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $35.3M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | — |
| 自由现金流率自由现金流/营收 | 6.6% | — |
| 资本支出强度资本支出/营收 | 4.6% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $91.8M | — |
8季度趋势，按日历期对齐
经营现金流ICUIKOS
| Q4 25 | $60.6M | $35.3M | ||
| Q3 25 | $56.7M | $-27.6M | ||
| Q2 25 | $11.2M | $127.2M | ||
| Q1 25 | $51.3M | $-888.0K | ||
| Q4 24 | $40.2M | $175.7M | ||
| Q3 24 | $36.1M | $6.3M | ||
| Q2 24 | $82.0M | $223.7M | ||
| Q1 24 | $45.8M | $272.6M |
自由现金流ICUIKOS
| Q4 25 | $36.0M | — | ||
| Q3 25 | $27.6M | — | ||
| Q2 25 | $-8.5M | — | ||
| Q1 25 | $36.7M | — | ||
| Q4 24 | $16.1M | — | ||
| Q3 24 | $16.2M | — | ||
| Q2 24 | $62.5M | — | ||
| Q1 24 | $29.9M | — |
自由现金流率ICUIKOS
| Q4 25 | 6.6% | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | -1.5% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 10.5% | — | ||
| Q1 24 | 5.3% | — |
资本支出强度ICUIKOS
| Q4 25 | 4.6% | — | ||
| Q3 25 | 5.4% | — | ||
| Q2 25 | 3.6% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | 2.8% | — |
现金转化率ICUIKOS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.32× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 3.74× | ||
| Q1 24 | — | 2.97× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
KOS
| Ghana Segment | $134.6M | 46% |
| Gulf Of America | $80.7M | 27% |
| Mauritania And Senegal | $54.9M | 19% |
| Equatorial Guinea Segment | $24.3M | 8% |
